Chemed Corporation (CHE) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 9 analysts8.9% Below Target
CHE trades 8.9% below Wall Street's consensus target of $475.00.
Current Price$436.27
Average Target$475.00
Low$475.00
Median$475.00
High$475.00
Analyst Target Range
Forward P/E17.9x
(Fair)
PEG Ratio—
Implied Growth+28.2%
(High Growth)
Analyst Spread0.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes CHE achieves its forward estimates and maintains a stable P/E multiple of 17.9x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
CHE Price Target Analysis
Updated June 22, 2026As of June 22, 2026, Chemed Corporation (CHE) has a Wall Street consensus price target of $475.00, based on estimates from 9 covering analysts. With the stock currently trading at $436.27, this represents a potential upside of +8.9%. The company has a market capitalization of $5.97B.
Analyst price targets range from a low of $475.00 to a high of $475.00, representing a 0% spread in expectations. The median target of $475.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CHE trades at a trailing P/E of 23.7x and forward P/E of 17.9x. Analysts expect EPS to grow +28.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $572.19, with bear and bull scenarios of $360.48 and $753.92 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+20.9%
Industry Consensus
Avg Forward P/E
18.8x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ADUSAddus HomeCare Corporation | $1.8B | $94.23 | $122.00 | +29.5% | Buy | 13.5x | 16 |
 ENSGThe Ensign Group, Inc. | $9.0B | $153.65 | $222.33 | +44.7% | Buy | 20.3x | 13 |
 SCIService Corporation International | $10.1B | $72.62 | $93.00 | +28.1% | Buy | 17.6x | 10 |
 CSVCarriage Services, Inc. | $605M | $38.16 | $50.00 | +31.0% | Buy | 11.1x | 7 |
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.94 | $24.50 | +6.8% | Hold | 21.2x | 15 |
 OPCHOption Care Health, Inc. | $3.4B | $21.99 | $31.22 | +42.0% | Buy | 12.0x | 14 |
 UNHUnitedHealth Group Incorporated | $363.9B | $400.96 | $425.81 | +6.2% | Buy | 21.8x | 52 |
 HUMHumana Inc. | $43.3B | $360.65 | $298.50 | -17.2% | Hold | 40.8x | 44 |
 CVSCVS Health Corporation | $125.4B | $98.32 | $103.64 | +5.4% | Buy | 13.3x | 41 |
 MCKMcKesson Corporation | $90.2B | $750.63 | $994.86 | +32.5% | Buy | 17.0x | 31 |
CHE — Frequently Asked Questions
Quick answers to the most common questions about buying CHE stock.
What is the CHE stock price target for 2026?
The consensus price target for CHE is $475, close to the current price of $436.27 (8.9% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.
Is CHE a buy, sell, or hold?
CHE has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $475 implies 8.9% upside from current levels.
Is CHE stock overvalued or undervalued?
With a forward P/E of 17.9148x, CHE trades at a relatively low valuation. The consensus target of $475 implies 8.9% appreciation, suggesting the market may be pricing in risks.
How high can CHE stock go?
The most bullish Wall Street analyst has a price target of $475 for CHE, while the most conservative target is $475. The consensus of $475 represents the median expectation. Our quantitative valuation model projects a bull case target of $754 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CHE stock?
CHE is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CHE stock forecast?
The 12-month CHE stock forecast based on 9 Wall Street analysts shows a consensus price target of $475, with estimates ranging from $475 (bear case) to $475 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $572, with bear/bull scenarios of $360/$754.
What is CHE's fair value based on fundamentals?
Our quantitative valuation model calculates CHE's fair value at $572 (base case), with a bear case of $360 and bull case of $754. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
What is CHE's forward P/E ratio?
CHE trades at a forward P/E ratio of 17.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CHE stock?
CHE appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $475 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CHE price targets vary so much?
CHE analyst price targets range from $475 to $475, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $475 consensus represents the middle ground. Our model's $360-$754 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare